Russia Gets Ready to Roll Out Omicron Boosters on a Whirlwind
On Monday, Moscow declared it’s all set to fire off booster shots for the new Omicron strain—if the need shows up. Meanwhile, the Kremlin brushed off the nervous market jitters as “just an emotional reaction” that lacks hard science.
Why the Buzz Is Rising
- Worse‑mutated Omicron has been causing investors to scramble for safety on Friday.
- WHO flags it as likely to spread worldwide, raising the risk of big infection spikes that could hit hard in some spots.
Russia’s Vaccine Arsenal
Russia was quick to spin up its Sputnik V (a two‑dose jab) last year and also rolled out a one‑shot Sputnik Light. Both claim high efficacy in trials, although they’re still in line for the WHO green light.
Manufacturers admit they’re having trouble producing the second dose, which has slowed the push to increase output at home.
Gamelya’s Confidence in Omicron
The Gamaleya Institute is confident that its vaccine will keep up against Omicron, and that the country can mass‑produce “hundreds of millions” of boosters if needed.
Kirill Dmitriev, head of the Russian Direct Investment Fund (the global marketer), shared the optimism on Sputnik V’s Twitter:
“Gamaleya Institute believes Sputnik V and Light will neutralise Omicron as they have highest efficacy versus other mutations,”
“If we need to tweak it, we’ll have several hundred million Sputnik Omicron boosters ready by 20 Feb 2022.”
And yes, that’s officially the tweet: @sputnikvaccine (though we’re not putting a link here per the rules).
Spokesperson’s Say‑So
Dmitry Peskov, the Kremlin’s spokesperson, told reporters the market’s reaction is “emotional” and not grounded in solid evidence—because there’s no evidence yet. “Everyone’s trying to figure out how dangerous it is,” he said.
Stay Tuned
With Spain reporting its first Omicron case and Covid‑19 infections climbing, you can bet this story will keep unfolding.
